Argus Research Maintains Buy on Sanofi, Raises Price Target to $60
Portfolio Pulse from Benzinga Newsdesk
Argus Research has maintained its Buy rating on Sanofi (NASDAQ:SNY) and raised the price target from $55 to $60.
July 26, 2024 | 7:24 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Argus Research has maintained its Buy rating on Sanofi and raised the price target from $55 to $60.
The raised price target and maintained Buy rating from Argus Research are positive signals for investors, likely leading to increased investor confidence and potential short-term price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100